F-X. Nouhaud

Lymphoma Study Association

Papers

2

Total Citations

70

H-Index

2

About

A leading authority in urologic oncology, Dr. F.-X. Nouhaud has made significant contributions to the management of kidney cancer, particularly through his work with the French AFU Cancer Committee. He is the lead author of the influential "French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer," which has garnered 51 citations and serves as a cornerstone for clinical practice in France. Dr. Nouhaud’s research has also advanced the surgical treatment of renal tumors, as demonstrated by his landmark comparative study of 1,800 robotic versus open partial nephrectomies (19 citations). This work has helped clarify the benefits of minimally invasive approaches, guiding surgeons in optimizing patient outcomes. His expertise spans guideline development, surgical innovation, and evidence-based oncology, making him a key figure in shaping modern urological care. With a focus on translating research into actionable clinical recommendations, Dr. Nouhaud continues to influence both national treatment standards and the broader field of kidney cancer management.

Research Focus

Key Achievements

2
H-Index
2
Papers
70
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
51 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Lymphoma Study Association

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago